An Overview of Breast Cancer Screening Recommendations
Breast Cancer is the most common type of cancer in women and the second leading cause of cancer related deaths next to lung cancer. Although men can also get breast cancer, cases of male breast cancer account for less than 0.05% of all breast cancer diagnosed. If eight women live to the age of 85, at least one of them will develop breast cancer in her lifetime. Twothirds of women diagnosed with breast cancer are over the age of 50, and the majority of remaining is between age of 39 and 40. Still there lies some confusion when it comes to Breast Cancer screening. So here are some recommendations for breast cancer screening.
Mini Review
Definitely beneficial, recommended: Mammogram every 2 years for women age 50-74.
Genetic counseling and possible testing for women with evidence of high risk family history which includes:
- Two 1st degree relatives with breast cancer, including age>50.
- Three or more 1st or 2nd degree relative with breast cancer.
- 1st or 2nd degree relative with breast and ovarian cancer.
- 1st degree relative with bilateral breast cancer.
- Breast Cancer in a male relative.
Ashkenazi Jewish women with any 1st or 2nd degree relative with breast or ovarian cancer
- Possibly Beneficial, Individualize: Mammogram in women before age 50.
- Definitely not Beneficial, Not Recommended: Breast self examination at any age.
Genetic testing for women without high risk family history
Uncertain Benefit: Mammogram in women age>age 75, Clinical Breast examination, MRI of the breasts [1, 2, 3, 4, 5, 6, 7, 8, 9, 10].
References
-
U.S. Preventive Services task Force (2002) Screening For Breast Cancer recommendation of rationale. Ann Intern Med 137(5): 344-346.
-
Humphrey LL, Helfand M, Chan BK, Woolf SH (2000) Breast Cancer Screening. Rockville.
-
Humphrey LL, Helfand M, Chan BK, Woolf SH (2002) Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137(5): 347-360.
-
Simpson JF, Wilkinson E J (2004) Malignant Neoplasiao if the Breast: Infiltrating carcinomas. In: Bland KI, Copeland EM (Eds.), 3rd (Edn.), St Louis, Saunders.
-
Swhartz GF (2004) Biology and management of lobular carcinoma in situ of breast. In: Bland KI, Copeland EM (Eds.), 3rd (Edn.), St Louis, Saunders.
-
Page DL, LagoisMD (2004) In situ carcinomas of the breast, ductal carcinoma in situ, pagets disease, lobular carcinoma in situ. In: Bland KI, Copeland EM (Eds.), 3rd (Edn.), St Louis, Saunders.
-
(2004) American Cancer Society, cancer facts and figures.
-
(2008) American Cancer Society Statistics.
-
Ries LAG, Melbert D, Krapcho M, Miller BA, Eric J Feuer, et al. (2006) SEER Cancer Statistics review, 1975-2004.
-
Ries LAG, Harkins D, Krapcho M, Miller BA, Eric J Feuer, et al. (2005) SEER Cancer Statistics review, 1975-2003. Bethesda, MD: National Cancer Institute based on november 2005 SEER data submission, posted to the SEER website 2006.
- Postpartum Maternal Mental Health - A Narrative Review
- Beta HCG in Cervico-Vaginal Secretion as a Predictor of Preterm Delivery
- Successful Management of Mid Trimester Foetal Death with Major Placenta Previa by Expectant Management Followed by Induction of Labour
- To Evaluate the Expression of Egr2 Gene in Term Low Birth Weight Newborns
- Impact of Maternal Obesity on Maternal and Foetal Outcomes: A Prospective Cohort Study from Northern India
- ‘’Benefit of Pulsatile GnRH Therapy in Treatment of Functional Hypothalamic Amenorrhea (FHA) and Congenital Hypogonadotropic Hypogonadism(CHH) in Infertile Patients Over Canonical Gonadotropins with IVF –A Short Communication’’